Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Xeris Biopharma Holdings, Inc. - Common Stock (NQ:XERS)

5.085 +0.215 (+4.41%)
Streaming Delayed Price Updated: 1:55 PM EDT, May 20, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 1,281,566
Open 4.920
Bid (Size) 5.080 (19)
Ask (Size) 5.090 (5)
Prev. Close 4.870
Today's Range 4.850 - 5.115
52wk Range 1.860 - 6.070
Shares Outstanding 66,497,370
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Xeris Announces Details for Analyst & Investor Day
From Xeris Biopharma Holdings, Inc.
Via Business Wire
XERIS BIOPHARMA HOLDINGS INC (NASDAQ:XERS) – A High-Growth Stock Meeting Minervini’s Trend Template
XERIS BIOPHARMA (XERS) meets Minervini’s Trend Template with strong technicals and high-growth fundamentals, making it a stock to watch for momentum investors. 
Via Chartmill

Performance

YTD
+47.0%
+47.0%
1 Month
+26.5%
+26.5%
3 Month
+31.4%
+31.4%
6 Month
+75.3%
+75.3%
1 Year
+148.0%
+148.0%

More News

Read More
Xeris Biopharma Reports Record First Quarter 2025 Financial Results
From Xeris Biopharma Holdings, Inc.
Via Business Wire
Earnings Scheduled For May 8, 2025
Via Benzinga
Earnings Outlook For Xeris Biopharma Holdings
Via Benzinga
Earnings Outlook For Xeris Biopharma Holdings
Via Benzinga
Xeris Biopharma to Report First Quarter 2025 Financial Results on May 8, 2025
From Xeris Biopharma Holdings, Inc.
Via Business Wire
Bright Peak Therapeutics Appoints John Schmid to its Board of Directors
From Bright Peak Therapeutics, Inc.
Via GlobeNewswire
Would Mark Minervini consider XERIS BIOPHARMA HOLDINGS INC (NASDAQ:XERS) a top stock pick?
Via Chartmill
Xeris Announces Changes to Its Board of Directors
From Xeris Biopharma Holdings, Inc.
Via Business Wire
Xeris Announces Approval of Supplemental New Drug Application (sNDA) of Gvoke VialDx™ (glucagon) for Use as a Diagnostic Aid
From Xeris Biopharma Holdings, Inc.
Via Business Wire
Xeris Biopharma - Possibly The Best Pharma Stock
Via Talk Markets
Topics Stocks / Equities
Xeris Biopharma Stock Soars To Nearly 4-Year High On Strong 2025 Outlook, Retail Bulls Charge In
Via Stocktwits
These stocks are gapping in today's session
Via Chartmill
Xeris Biopharma Delivers Record Fourth Quarter and Full-Year 2024 Results; and Announces 2025 Guidance
From Xeris Biopharma Holdings, Inc.
Via Business Wire
Xeris Biopharma to Report Fourth Quarter and Full-Year 2024 Financial Results on March 6, 2025
From Xeris Biopharma Holdings, Inc.
Via Business Wire
Xeris Appoints Anh Nguyen, MD, MBA as Chief Medical Officer
From Xeris Biopharma Holdings, Inc.
Via Business Wire
Earnings Scheduled For March 6, 2025
Via Benzinga
Xeris to Participate in Upcoming Investor Conferences
From Xeris Biopharma Holdings, Inc.
Via Business Wire
Xeris Expects to Exceed Full-Year 2024 Financial Guidance
From Xeris Biopharma Holdings, Inc.
Via Business Wire
Xeris Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
From Xeris Biopharma Holdings, Inc.
Via Business Wire
Xeris to Participate in Piper Sandler 36th Annual Healthcare Conference
From Xeris Biopharma
Via Business Wire
Sapiens International Posts Downbeat Results, Joins Sky Harbour And Other Big Stocks Moving Lower In Monday's Pre-Market Session
Via Benzinga
Xeris Biopharma Reports Third Quarter 2024 Financial Results
From Xeris Biopharma Holdings, Inc.
Via Business Wire
Xeris Biopharma to Report Third Quarter 2024 Financial Results on November 8, 2024
From Xeris Biopharma Holdings, Inc.
Via Business Wire

Frequently Asked Questions

Is Xeris Biopharma Holdings, Inc. - Common Stock publicly traded?
Yes, Xeris Biopharma Holdings, Inc. - Common Stock is publicly traded.
What exchange does Xeris Biopharma Holdings, Inc. - Common Stock trade on?
Xeris Biopharma Holdings, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Xeris Biopharma Holdings, Inc. - Common Stock?
The ticker symbol for Xeris Biopharma Holdings, Inc. - Common Stock is XERS on the Nasdaq Stock Market
What is the current price of Xeris Biopharma Holdings, Inc. - Common Stock?
The current price of Xeris Biopharma Holdings, Inc. - Common Stock is 5.085
When was Xeris Biopharma Holdings, Inc. - Common Stock last traded?
The last trade of Xeris Biopharma Holdings, Inc. - Common Stock was at 05/20/25 01:55 PM ET
What is the market capitalization of Xeris Biopharma Holdings, Inc. - Common Stock?
The market capitalization of Xeris Biopharma Holdings, Inc. - Common Stock is 338.14M
How many shares of Xeris Biopharma Holdings, Inc. - Common Stock are outstanding?
Xeris Biopharma Holdings, Inc. - Common Stock has 338M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.